Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Lilly Leaps Into China Broad Diabetes Market, Echoing Sanofi, Novo

This article was originally published in PharmAsia News

Executive Summary

Signaling a new direction, Lilly is embracing China's vast county hospital market for its diabetes care products through a new access initiative, following in the footsteps of rivals Sanofi and Novo Nordisk but with a bolder and broader approach.


Related Content

2016 Review: Pricing, R&D Issues Dominate China Commercial Arena


Related Companies